Identification and validation of lncRNA mutation hotspot SNPs associated with myasthenia gravis susceptibility
Source: Non-coding RNA Research
Features of myositis and myasthenia gravis in patients treated with immune checkpoint inhibitors: a multicentric, retrospective cohort study
Source: The Lancet Regional Health - Europe
Seasonal variation in myasthenia gravis incidence
Source: Journal of Neuroimmunology
Therapeutic development towards T follicular helper cells as a molecular target in myasthenia gravis disease
Source: Journal of Neuroimmunology
Sirt6, Deubiquitinated and Stabilised by USP9X, Takes Essential Actions on the Pathogenesis of Experimental Autoimmune Myasthenia Gravis by Regulating CD4<sup>+</sup> T Cells
Source: Clinical and Experimental Pharmacology and Physiology
For Patient Families
To support patients and caregivers, Elsevier Health is making the latest research on these rare disorders available upon request at no cost.
Learn More
Note:
User acknowledges that these materials are provided for use at no charge as part of Elsevier’s efforts to support healthcare providers and patients. The information contained within the website is intended as a supplement to, and not a substitute for, the knowledge, expertise, skill and judgment of healthcare professionals involved in patient care. The content within this page may not be re-used, modified or re-distributed without prior written permission.
Cookies are used by this site. To decline or learn more, visit our cookie notice.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
